Carol Ott, Pharm.D., BCPP - Clinical Professor of Pharmacy Practice, Purdue University College of Pharmacy and Residency Program Director for the Eskenazi Health/Purdue University PGY2 Psychiatric Pharmacy Residency Program - discusses how sigma adversely impacts patients with opioid use disorder and how the BoilerwoRx program is helping to address the opioid crises at the community level.
Key Lessons
- Health professionals too often use stigmatizing language when describing patients with a substance use disorder and their behaviors.
- We need to critically examine our unconscious biases toward patients with substance use disorder.
- Substance use disorders are most often co-morbid with other mental health conditions.
- Needle exchange programs are an evidence-based intervention that can reduce harm by preventing the spread of infectious diseases and be an important touchpoint to get people into treatment.
- There are numerous ways pharmacists can help patients with substance use disorders - approaching them with empathy, volunteering, and using evidence-based resources to guide care and combat misinformation.
View and Download the ShowNotes!
